{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:27:43Z","timestamp":1790216863357,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016230","name":"Steven & Alexandra Cohen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known about risk factors for early (e.g., erythema migrans) and disseminated Lyme disease manifestations, such as arthritis, neurological complications, and carditis. No study has used both diagnoses and free text to classify Lyme disease by disease stage and manifestation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We identified Lyme disease cases in 2012\u20132016 in the electronic health record (EHR) of a large, integrated health system in Pennsylvania. We developed a rule-based text-matching algorithm using regular expressions to extract clinical data from free text. Lyme disease cases were then classified by stage and manifestation using data from both diagnoses and free text. Among cases classified by stage, we evaluated individual, community, and health care variables as predictors of disseminated stage (vs. early) disease using Poisson regression models with robust errors. Final models adjusted for sociodemographic factors, receipt of Medical Assistance (i.e., Medicaid, a proxy for low socioeconomic status), primary care contact, setting of diagnosis, season of diagnosis, and urban\/rural status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 7310 cases of Lyme disease, we classified 62% by stage. Overall, 23% were classified using both diagnoses and text, 26% were classified using diagnoses only, and 13% were classified using text only. Among the staged diagnoses (n\u2009=\u20094530), 30% were disseminated stage (762 arthritis, 426 neurological manifestations, 76 carditis, 95 secondary erythema migrans, and 76 other manifestations). In adjusted models, we found that persons on Medical Assistance at least 50% of time under observation, compared to never users, had a higher risk (risk ratio [95% confidence interval]) of disseminated Lyme disease (1.20 [1.05, 1.37]). Primary care contact (0.59 [0.54, 0.64]) and diagnosis in the urgent care (0.22 [0.17, 0.29]), compared to the outpatient setting, were associated with lower risk of disseminated Lyme disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The associations between insurance payor, primary care status, and diagnostic setting with disseminated Lyme disease suggest that lower socioeconomic status and less health care access could be linked with disseminated stage Lyme disease. Intervening on these factors could reduce the individual and health care burden of disseminated Lyme disease. Our findings demonstrate the value of both diagnostic and narrative text data to identify Lyme disease manifestations in the EHR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06959-y","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T12:02:48Z","timestamp":1640001768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk factors for Lyme disease stage and manifestation using electronic health records"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-075X","authenticated-orcid":false,"given":"Katherine A.","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa N.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie G.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"3","key":"6959_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/ilar\/ilx005","volume":"58","author":"RJ Eisen","year":"2017","unstructured":"Eisen RJ, Kugeler KJ, Eisen L, Beard CB, Paddock CD. Tick-borne zoonoses in the United States: persistent and emerging threats to human health. ILAR J. 2017;58(3):319\u201335.","journal-title":"ILAR J"},{"issue":"2","key":"6959_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3201\/eid2702.202731","volume":"27","author":"KJ Kugeler","year":"2021","unstructured":"Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of lyme disease diagnoses, United States, 2010\u20132018. Emerg Infect Dis. 2021;27(2):616\u20139.","journal-title":"Emerg Infect Dis"},{"key":"6959_CR3","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, et al. Lyme borreliosis. Nat Rev Dis Prim. 2016;2:16090.","journal-title":"Nat Rev Dis Prim"},{"issue":"24","key":"6959_CR4","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","volume":"348","author":"AC Steere","year":"2003","unstructured":"Steere AC, Sikand VK. The presenting manifestations of lyme disease. N Engl J Med. 2003;348(24):2472\u20134.","journal-title":"N Engl J Med"},{"issue":"9","key":"6959_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089\u2013134.","journal-title":"Clin Infect Dis"},{"issue":"16","key":"6959_CR6","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1001\/jama.2016.2884","volume":"315","author":"E Sanchez","year":"2016","unstructured":"Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315(16):1767\u201377.","journal-title":"JAMA"},{"issue":"5","key":"6959_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jme\/tjw092","volume":"53","author":"L Eisen","year":"2016","unstructured":"Eisen L, Eisen RJ. Critical evaluation of the linkage between tick-based risk measures and the occurrence of lyme disease cases. J Med Entomol. 2016;53(5):1050\u201362.","journal-title":"J Med Entomol"},{"issue":"23","key":"6959_CR8","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/jama.297.23.2617","volume":"297","author":"CD Tibbles","year":"2007","unstructured":"Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007;297(23):2617\u201327.","journal-title":"JAMA"},{"key":"6959_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2334-9-79","volume":"9","author":"J Aucott","year":"2009","unstructured":"Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early lyme disease: lessons from a community case series. BMC Infect Dis. 2009;9:79.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6959_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx254","volume":"5","author":"NA Kwit","year":"2018","unstructured":"Kwit NA, Nelson CA, Max R, Mead PS. Risk factors for clinician-diagnosed lyme arthritis, facial palsy, carditis, and meningitis in patients from high-incidence states. Open Forum Infect Dis. 2018;5(1): ofx254.","journal-title":"Open Forum Infect Dis"},{"issue":"22","key":"6959_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","volume":"66","author":"AM Schwartz","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for lyme disease\u2014United States, 2008\u20132015. MMWR Surveill Summ. 2017;66(22):1.","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"6959_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064110","volume":"8","author":"F Strle","year":"2013","unstructured":"Strle F, Wormser GP, Mead P, Dhaduvai K, Longo MV, Adenikinju O, et al. Gender disparity between cutaneous and non-cutaneous manifestations of lyme borreliosis. PLoS ONE. 2013;8(5): e64110.","journal-title":"PLoS ONE"},{"issue":"8","key":"6959_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/aje\/152.8.756","volume":"152","author":"AD Fix","year":"2000","unstructured":"Fix AD, Pe\u00f1a CA, Strickland GT. Racial differences in reported lyme disease incidence. Am J Epidemiol. 2000;152(8):756\u20139.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"6959_CR14","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1542\/peds.2008-3058","volume":"123","author":"JM Costello","year":"2009","unstructured":"Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics. 2009;123(5):e835\u201341.","journal-title":"Pediatrics"},{"issue":"6","key":"6959_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198509","volume":"13","author":"KO Johnson","year":"2018","unstructured":"Johnson KO, Nelder MP, Russell C, Li Y, Badiani T, Sander B, et al. Clinical manifestations of reported lyme disease cases in Ontario, Canada: 2005\u20132014. PLoS ONE. 2018;13(6): e0198509.","journal-title":"PLoS ONE"},{"issue":"43","key":"6959_CR16","first-page":"982","volume":"63","author":"JD Forrester","year":"2014","unstructured":"Forrester JD, Meiman J, Mullins J, Nelson R, Ertel SH, Cartter M, et al. Notes from the field: update on lyme carditis, groups at high risk, and frequency of associated sudden cardiac death\u2014United States. MMWR Morb Mortal Wkly Rep. 2014;63(43):982\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"6959_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.diagmicrobio.2017.09.007","volume":"89","author":"E Weitzner","year":"2017","unstructured":"Weitzner E, Visintainer P, Wormser GP. Impact of patient age on clinical features, serologic test reactivity and long-term outcome of culture-confirmed early lyme disease. Diagn Microbiol Infect Dis. 2017;89(4):300\u20132.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"6959_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.diagmicrobio.2016.04.012","volume":"85","author":"E Weitzner","year":"2016","unstructured":"Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early lyme disease at presentation and at 11\u201320 years after diagnosis. Diagn Microbiol Infect Dis. 2016;85(4):493\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"6959_CR19","doi-asserted-by":"publisher","first-page":"h1885","DOI":"10.1136\/bmj.h1885","volume":"350","author":"KP Liao","year":"2015","unstructured":"Liao KP, Cai T, Savova GK, Murphy SN, Karlson EW, Ananthakrishnan AN, et al. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ. 2015;350:h1885\u2013h1885.","journal-title":"BMJ"},{"issue":"2","key":"6959_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ttbdis.2018.10.010","volume":"10","author":"KA Moon","year":"2019","unstructured":"Moon KA, Pollak J, Hirsch AG, Aucott JN, Nordberg C, Heaney CD, et al. Epidemiology of lyme disease in Pennsylvania 2006\u20132014 using electronic health records. Ticks Tick Borne Dis. 2019;10(2):241\u201350.","journal-title":"Ticks Tick Borne Dis"},{"issue":"April","key":"6959_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2019.108649","volume":"178","author":"KA Moon","year":"2019","unstructured":"Moon KA, Pollak J, Poulsen MN, Hirsch AG, DeWalle J, Heaney CD, et al. Peridomestic and community-wide landscape risk factors for Lyme disease across a range of community contexts in Pennsylvania. Environ Res. 2019;178(April): 108649.","journal-title":"Environ Res"},{"issue":"10","key":"6959_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/vbz.2015.1790","volume":"15","author":"Y-J Tseng","year":"2015","unstructured":"Tseng Y-J, Cami A, Goldmann DA, DeMaria A, Mandl KD. Using nation-wide health insurance claims data to augment lyme disease surveillance. Vector-Borne Zoonotic Dis. 2015;15(10):591\u20136.","journal-title":"Vector-Borne Zoonotic Dis"},{"issue":"9","key":"6959_CR23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/cid\/civ584","volume":"61","author":"PM Lantos","year":"2015","unstructured":"Lantos PM, Branda JA, Boggan JC, Chudgar SM, Wilson EA, Ruffin F, et al. Poor positive predictive value of lyme disease serologic testing in an area of low disease incidence. Clin Infect Dis. 2015;61(9):1374\u201380.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"6959_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","volume":"21","author":"CA Nelson","year":"2015","unstructured":"Nelson CA, Saha S, Kugeler KJ, Delorey MJ, Shankar MB, Hinckley AF, et al. Incidence of clinician-diagnosed lyme disease, United States, 2005\u20132010. Emerg Infect Dis. 2015;21(9):1625\u201331.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"6959_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","volume":"8","author":"KE Eliassen","year":"2017","unstructured":"Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, et al. Incidence and antibiotic treatment of erythema migrans in Norway 2005\u20132009. Ticks Tick Borne Dis. 2017;8(1):1\u20138.","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"6959_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-018-0729-2","volume":"19","author":"E Botman","year":"2018","unstructured":"Botman E, Ang CW, Joosten JHK, Slottje P, Van Der Wouden JC, Maarsingh OR. Diagnostic behaviour of general practitioners when suspecting lyme disease: a database study from 2010\u20132015. BMC Fam Pract. 2018;19(1):1\u20139.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"6959_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4269\/ajtmh.13-0180","volume":"90","author":"SM Moore","year":"2014","unstructured":"Moore SM, Eisen RJ, Monaghan A, Mead P. Meteorological influences on the seasonality of lyme disease in the United States. Am J Trop Med Hyg. 2014;90(3):486\u201396.","journal-title":"Am J Trop Med Hyg"},{"issue":"1665","key":"6959_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.2013.0556","volume":"370","author":"T Levi","year":"2015","unstructured":"Levi T, Keesing F, Oggenfuss K, Ostfeld RS. Accelerated phenology of blacklegged ticks under climate warming. Philos Trans R Soc B Biol Sci. 2015;370(1665):1\u20138.","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"5114","key":"6959_CR29","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1126\/science.8503006","volume":"260","author":"AG Barbour","year":"1993","unstructured":"Barbour AG, Fish D. The biological and social phenomenon of lyme disease. Science (80-). 1993;260(5114):1610\u20136.","journal-title":"Science (80-)"},{"key":"6959_CR30","unstructured":"Centers for Medicare & Medicaid Services. Medicaid & CHIP in Pennsylvania. 2020. https:\/\/www.medicaid.gov\/state-overviews\/stateprofile.html?state=pennsylvania."},{"issue":"3","key":"6959_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.amepre.2017.10.004","volume":"54","author":"JA Casey","year":"2018","unstructured":"Casey JA, Pollak J, Glymour MM, Mayeda ER, Hirsch AG, Schwartz BS. Measures of SES for electronic health record-based research. Am J Prev Med. 2018;54(3):430\u20139.","journal-title":"Am J Prev Med"},{"issue":"2","key":"6959_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","volume":"29","author":"PS Mead","year":"2015","unstructured":"Mead PS. Epidemiology of lyme disease. Infect Dis Clin North Am. 2015;29(2):187\u2013210.","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"6959_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","volume":"18","author":"V Seriburi","year":"2012","unstructured":"Seriburi V, Ndukwe N, Chang Z, Cox ME, Wormser GP. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect. 2012;18(12):1236\u201340.","journal-title":"Clin Microbiol Infect"},{"issue":"31","key":"6959_CR34","first-page":"590","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","unstructured":"Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of lyme disease. MMWR. 1995;44(31):590\u20131.","journal-title":"MMWR"},{"key":"6959_CR35","unstructured":"U.S. Census Bureau. 2010 census urban and rural classification and urban area criteria. 2018. https:\/\/www.census.gov\/programs-surveys\/geography\/guidance\/geo-areas\/urban-rural\/2010-urban-rural.html. Accessed 11 Dec 2019."},{"issue":"6","key":"6959_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","volume":"129","author":"N Douthit","year":"2015","unstructured":"Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611\u201320.","journal-title":"Public Health"},{"issue":"7","key":"6959_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"e1","key":"6959_CR38","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1136\/amiajnl-2012-000896","volume":"20","author":"KM Newton","year":"2013","unstructured":"Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inf Assoc. 2013;20(e1):e147\u201354.","journal-title":"J Am Med Inf Assoc"},{"issue":"2","key":"6959_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/zph.12448","volume":"65","author":"ML Cartter","year":"2018","unstructured":"Cartter ML, Lynfield R, Feldman KA, Hook SA, Hinckley AF. Lyme disease surveillance in the United States: looking for ways to cut the Gordian knot. Zoonoses Public Health. 2018;65(2):227\u20139.","journal-title":"Zoonoses Public Health"},{"key":"6959_CR40","unstructured":"Henry J. Kaiser Family Foundation. Medicaid and CHIP eligibility, enrollment, renewal, and cost-sharing policies as of January 2020: findings from a 50-state survey. 2020. https:\/\/www.kff.org\/medicaid\/report\/medicaid-and-chip-eligibility-enrollment-and-cost-sharing-policies-as-of-january-2020-findings-from-a-50-state-survey\/."},{"key":"6959_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-021367","volume":"8","author":"AG Hirsch","year":"2018","unstructured":"Hirsch AG, Herman RJ, Rebman A, Moon KA, Aucott J, Heaney C, et al. Obstacles to diagnosis and treatment of lyme disease in the USA: a qualitative study. BMJ Open. 2018;8:1\u20137.","journal-title":"BMJ Open"},{"key":"6959_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1055\/s-0038-1638592","volume":"17","author":"SM Meystre","year":"2008","unstructured":"Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF. Extracting information from textual documents in the electronic health record: a review of recent research. Yearb Med Inform. 2008;17:128\u201344.","journal-title":"Yearb Med Inform"},{"issue":"11","key":"6959_CR43","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.7326\/M19-0873","volume":"172","author":"A Callahan","year":"2020","unstructured":"Callahan A, Shah NH, Chen JH. Research and reporting considerations for observational studies using electronic health record data. Ann Intern Med. 2020;172(11):S79\u201384.","journal-title":"Ann Intern Med"},{"issue":"2","key":"6959_CR44","first-page":"163","volume":"27","author":"JA Casey","year":"2016","unstructured":"Casey JA, Savitz DA, Rasmussen SG, Ogburn EL, Pollak J, Mercer DG, et al. Unconventional natural gas development and birth outcomes in Pennsylvania. USA Epidemiol. 2016;27(2):163\u201372.","journal-title":"USA Epidemiol"},{"issue":"4","key":"6959_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cll.2015.08.004","volume":"35","author":"JL Sanchez","year":"2015","unstructured":"Sanchez JL. Clinical manifestations and treatment of lyme disease. Clin Lab Med. 2015;35(4):765\u201378.","journal-title":"Clin Lab Med"},{"issue":"2","key":"6959_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","volume":"29","author":"J Aucott","year":"2015","unstructured":"Aucott J. Posttreatment lyme disease syndrome. Infect Dis Clin North Am. 2015;29(2):309\u201323.","journal-title":"Infect Dis Clin North Am"},{"issue":"November","key":"6959_CR47","first-page":"1","volume":"7","author":"AG Hirsch","year":"2020","unstructured":"Hirsch AG, Poulsen MN, Nordberg C, Moon KA, Rebman AW, Aucott JN, et al. Risk factors and outcomes of treatment delays in lyme disease: a population-based retrospective cohort study. Front Med. 2020;7(November):1\u201310.","journal-title":"Front Med"},{"issue":"2","key":"6959_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116767","volume":"10","author":"ER Adrion","year":"2015","unstructured":"Adrion ER, Aucott J, Lemke KW, Weiner JP. Health care costs, utilization and patterns of care following lyme disease. PLoS ONE. 2015;10(2): e0116767.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06959-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T07:04:50Z","timestamp":1676099090000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06959-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["6959"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06959-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Geisinger Institutional Review Board approved this study and waived informed consent. Data were collected for non-research purposes and consent was waived because it would be a burden on the patient if they would have to come into a visit to review and sign a consent, as some patients are not seen regularly. It would have been impractical for both the patient as well as study staff to contact thousands of patients to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1269"}}